Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.1.02253
European Journal of Endocrinology, Vol 155, Issue 4, 535-545
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gozu, H. I.
Right arrow Articles by Paschke, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gozu, H. I.
Right arrow Articles by Paschke, R.
CLINICAL STUDY

Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey

Hulya Iliksu Gozu1,*, Rifat Bircan4,*, Knut Krohn5, Sandra Müller6, Selahattin Vural2, Cem Gezen2, Haluk Sargin1, Dilek Yavuzer3, Mehmet Sargin1, Beyazit Cirakoglu4 and Ralf Paschke6

1 Section of Endocrinology and Metabolism and 2 Departments of General Surgery and 3 Pathology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, 34865 Istanbul, Turkey, 4 Department of Medical Biology, Marmara University Medical School, 34668 Istanbul, Turkey, and 5 Interdisciplinary Center of Clinical Research and 6 Department of Internal Medicine III, University of Leipzig, D-04103 Leipzig, Germany

(Correspondence should be addressed to R Paschke; Email: pasr{at}medizin.uni-leipzig.de)

Objective: Differences in iodine intake could account for the variable prevalences reported for somatic TSH receptor (TSHR) mutations in toxic thyroid nodules (TTNs). However, this question has not been settled, since no study has yet determined the TSHR mutation prevalence in regions with different iodine supplies in the same population using the same methodology. Therefore, we studied the prevalence of somatic TSHR mutations in TTNs from patients living in iodine-deficient or -sufficient regions in Turkey.

Design and methods: We screened 74 TTNs for somatic TSHR mutations. Exons 9 and 10 of the TSHR and 7 and 8 of the Gs{alpha} were screened by denaturing gradient gel electrophoresis. Determination of X-chromosome inactivation was used for clonality analysis.

Results: TSHR mutations were identified in 52 (70.2%) of 74 TTNs. A Gs{alpha} mutation was identified in one TTN. Three new TSHR mutations were detected (A627V, I640K, I486N). No significant difference between frequencies of TSHR mutations in iodine deficient/sufficient regions was found. The frequency of non-random X-chromosome inactivation was similar in iodine-sufficient or -deficient regions and in TSHR mutation positive or negative hot nodules.

Conclusions: These findings suggest that TTNs in iodine deficient/sufficient areas predominantly arise from aberrant growth of a single cell. Our results suggest that neither the prevalence of TSHR mutations nor that of monoclonal TTNs is related to iodine supply.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.